Camilla Appelgren is the chair of Mannheimer Swartling’s Healthcare and Life Sciences group. She has extensive experience advising clients in the pharmaceutical, medical technology, biotech, food and cosmetics industries.
Camilla’s work covers regulatory issues, contract negotiations, research collaborations, clinical trials, market access, licensing, and other commercial matters such as manufacturing, supply, and distribution. She also advises on healthcare compliance, including marketing, cooperation with healthcare professionals, and funding of external research projects.
Camilla regularly represents clients before Swedish authorities and courts in pricing, reimbursement and substitution matters, and also assists with corporate transactions, including acquisitions and investments within the life sciences sector.
Camilla has broad experience in complex data protection issues, particularly in clinical trials, and works with a wide range of clients — from established pharmaceutical and medical device companies to hospitals, research institutions and investors.
Camilla frequently lectures and publishes within the field and serves as an officer of the International Bar Association’s Healthcare and Life Sciences Law Committee. She is recognized as a Global Elite Thought Leader by Who’s Who Legal, a Leading Individual by The Legal 500, and has been ranked by Chambers for her excellence in compliance and regulatory matters.
